These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10971374)

  • 1. Oral terbinafine treatment for toenail onychomycosis: follow-up after 5-6 years.
    Molin L; Tarstedt M; Engman C
    Br J Dermatol; 2000 Sep; 143(3):682-3. PubMed ID: 10971374
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine.
    Watson AB; Marley JE; Ellis DH; Williams TG
    Australas J Dermatol; 1998 Feb; 39(1):29-30. PubMed ID: 9529685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral terbinafine treatment for toenail onychomycosis.
    De Berker D
    Br J Dermatol; 2001 May; 144(5):1098-9. PubMed ID: 11359413
    [No Abstract]   [Full Text] [Related]  

  • 4. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
    Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA
    J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing complications in the diabetic patient with toenail onychomycosis.
    Anarella JJ; Toth C; DeBello JA
    J Am Podiatr Med Assoc; 2001 Jun; 91(6):325-8. PubMed ID: 11420354
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of terbinafine for nondermatophyte and mixed nondermatophyte and dermatophyte toenail onychomycosis.
    Lebwohl MG; Daniel CR; Leyden J; Mormon M; Shavin JS; Tschen E; Weiss J; Zone J
    Int J Dermatol; 2001 May; 40(5):358-60. PubMed ID: 11555003
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of terbinafine for toenail onychomycosis. A multicenter trial of various treatment durations.
    Pollak R; Billstein SA
    J Am Podiatr Med Assoc; 2001 Mar; 91(3):127-31. PubMed ID: 11266494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of toe-nail onychomycosis treated with terbinafine.
    Brandrup F; Larsen PO
    Acta Derm Venereol; 1997 May; 77(3):238. PubMed ID: 9188883
    [No Abstract]   [Full Text] [Related]  

  • 9. Terbinafine (Lamisil) treatment of toenail onychomycosis in patients with insulin-dependent and non-insulin-dependent diabetes mellitus: a multicentre trial.
    Farkas B; Paul C; Dobozy A; Hunyadi J; Horváth A; Fekete G
    Br J Dermatol; 2002 Feb; 146(2):254-60. PubMed ID: 11903236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous terbinafine versus intermittent itraconazole for toenail onychomycosis.
    Warrick D; Church L
    J Fam Pract; 1999 Jul; 48(7):492-3. PubMed ID: 10428238
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trial: the safety of terbinafine in patients over the age of 60 years: a multicenter trial in onychomycosis of the feet.
    Smith EB; Stein LF; Fivenson DP; Atillasoy ES
    Int J Dermatol; 2000 Nov; 39(11):861-4. PubMed ID: 11123452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacoeconomic analysis of the new oral antifungal agents used to treat toenail onychomycosis in the USA.
    Gupta AK; Lambert J
    Int J Dermatol; 1999 Sep; 38 Suppl 2():53-64. PubMed ID: 10515529
    [No Abstract]   [Full Text] [Related]  

  • 13. Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis.
    Faergemann J; Anderson C; Hersle K; Hradil E; Nordin P; Kaaman T; Molin L; Pettersson A
    J Am Acad Dermatol; 1995 May; 32(5 Pt 1):750-3. PubMed ID: 7722020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of onychomycosis with terbinafine.
    Baudraz-Rosselet F; Rakosi T; Wili PB; Kenzelmann R
    Br J Dermatol; 1992 Feb; 126 Suppl 39():40-6. PubMed ID: 1531928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of onychomycosis with terbinafine in patients with Down's syndrome.
    Velthuis PJ; Nijenhuis M
    Br J Dermatol; 1995 Jul; 133(1):144-6. PubMed ID: 7669630
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis.
    Degreef H; del Palacio A; Mygind S; Ginter G; Pinto Soares A; Zuluaga de Cadena A
    Acta Derm Venereol; 1999 May; 79(3):221-3. PubMed ID: 10384922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (Diflucan) in the treatment of patients with toenail onychomycosis.
    Salo H; Pekurinen M
    Pharmacoeconomics; 2002; 20(5):319-24. PubMed ID: 11994041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous terbinafine or pulse itraconazole: a comparative study on onychomycosis.
    Bahadir S; Inalöz HS; Alpay K; Agaoglu C; Cimsit G; Parlat P
    J Eur Acad Dermatol Venereol; 2000 Sep; 14(5):422-3. PubMed ID: 11305391
    [No Abstract]   [Full Text] [Related]  

  • 19. Toenail onychomycosis in patients with acquired immune deficiency syndrome: treatment with terbinafine.
    Herranz P; García J; De Lucas R; González J; Peña JM; Díaz R; Casado M
    Br J Dermatol; 1997 Oct; 137(4):577-80. PubMed ID: 9390334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis.
    Warshaw EM; Nelson D; Carver SM; Zielke GR; Webster N; Lederle FA; Fett DD
    Int J Dermatol; 2005 Sep; 44(9):785-8. PubMed ID: 16135154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.